Ad
ATAI Short Information ATAI Life Sciences N.V.
home / stock / atai / atai short
Short Information | ATAI Life Sciences N.V. (NASDAQ:ATAI)
| Twenty Trading Day Totals | |
|---|---|
| Total Shorted Volume | 12,463,181 |
| Total Actual Volume | 48,671,846 |
| Short Trends | |
|---|---|
| Cover Days | 20 |
| Short Days | 0 |
| No Change Days | 0 |
| Averages | |
|---|---|
| Average Short Volume | 623,159 |
| Average Short Percentage | 24.14% |
Is there a ATAI Short Squeeze or Breakout about to happen?
See the ATAI Short Analysis for free Sign up or Login
Powered by Squeeze Report
ATAI Twenty Trading Day's Volume to Short Volume Chart
ATAI Twenty Trading Day Price Chart
ATAI Short Data Results Days
| Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
|---|---|---|---|---|---|---|---|
| 12-03-2024 | $1.67 | $1.63 | $1.7 | $1.6 | 1,104,798 | 279,273 | 25.28% |
| 12-02-2024 | $1.76 | $1.69 | $1.809 | $1.675 | 1,139,917 | 245,167 | 21.51% |
| 11-29-2024 | $1.75 | $1.78 | $1.78 | $1.72 | 658,932 | 116,331 | 17.65% |
| 11-27-2024 | $1.67 | $1.73 | $1.7599 | $1.67 | 1,153,714 | 251,188 | 21.77% |
| 11-26-2024 | $1.7 | $1.69 | $1.7599 | $1.67 | 1,128,342 | 249,852 | 22.14% |
| 11-25-2024 | $1.66 | $1.68 | $1.75 | $1.63 | 1,519,918 | 305,953 | 20.13% |
| 11-22-2024 | $1.52 | $1.61 | $1.71 | $1.42 | 2,115,327 | 448,401 | 21.2% |
| 11-21-2024 | $1.59 | $1.52 | $1.6 | $1.51 | 1,265,874 | 313,757 | 24.79% |
| 11-20-2024 | $1.75 | $1.59 | $1.788 | $1.54 | 2,353,110 | 577,161 | 24.53% |
| 11-19-2024 | $1.66 | $1.73 | $1.835 | $1.53 | 2,736,172 | 584,792 | 21.37% |
| 11-18-2024 | $1.65 | $1.67 | $1.95 | $1.54 | 7,252,889 | 1,773,167 | 24.45% |
| 11-15-2024 | $1.5 | $1.61 | $1.65 | $1.43 | 6,165,999 | 1,914,851 | 31.06% |
| 11-14-2024 | $1.39 | $1.37 | $1.41 | $1.25 | 1,860,827 | 451,884 | 24.28% |
| 11-13-2024 | $1.5 | $1.35 | $1.55 | $1.35 | 2,464,985 | 529,250 | 21.47% |
| 11-12-2024 | $1.6 | $1.46 | $1.651 | $1.39 | 2,997,646 | 904,049 | 30.16% |
| 11-11-2024 | $1.45 | $1.58 | $1.6 | $1.39 | 2,882,153 | 926,891 | 32.16% |
| 11-08-2024 | $1.37 | $1.41 | $1.48 | $1.28 | 2,861,663 | 804,265 | 28.1% |
| 11-07-2024 | $1.22 | $1.35 | $1.51 | $1.215 | 4,663,097 | 1,214,319 | 26.04% |
| 11-06-2024 | $1.13 | $1.18 | $1.21 | $1.1 | 1,809,324 | 473,509 | 26.17% |
| 11-05-2024 | $1.1 | $1.08 | $1.12 | $1.05 | 537,159 | 99,121 | 18.45% |
News, Short Squeeze, Breakout and More Instantly...
ATAI Life Sciences N.V. Company Name:
ATAI Stock Symbol:
NASDAQ Market:
ATAI Life Sciences N.V. Website:
Ad
-
A recently released report has determined that psilocybin possesses the potential to help manage mental health conditions like anxiety and depression in the context of end-of-life care and severe illness. The report was compiled by a task force in Vermont established... Read more » ...
-
- The United States Food and Drug Administration cleared the investigational new drug application for VLS-01 (buccal film DMT); atai expects to initiate a Phase 2 study in treatment-resistant depression patients around YE’24 - Remain on track to initiate a Phase 2 study of EMP-01 (...
-
GAITHERSBURG, Md., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced the appointment of Greg Weaver as Chief Financial Officer (CFO), effective immediately. Mr. Weaver will lead the Company’s finance and account...